Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 28Endometrial Neoplasms 9Vaginal Neoplasms 5Ovarian Neoplasms 5Vulvar Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Neoplasms 3Endometrial Clear Cell Adenocarcinoma 3Uterine Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Neoplasms 2Melanoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Peritoneal Neoplasms 1Pelvic Inflammatory Disease 1Patient Compliance 1Neoplasm Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma, Myxoid 1Hyperthermia 1Head and Neck Neoplasms 1HIV Infections 1Endometriosis 1Endometrial Adenocarcinoma 1Diarrhea 1

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Adenocarcinoma × Radiation × Gynecologic × Clear all
NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡